Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA).
- Disclosed ownership: 4.3%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 4.3% ownership in Kura Oncology, Inc. Common Stock, par value $0.0001 per share (KURA) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 2.2% | 1,751,852 | 0 | 1,751,852 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 2.2% | 1,751,852 | 0 | 1,751,852 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 1.8% | 1,410,347 | 0 | 1,410,347 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 1.8% | 1,410,347 | 0 | 1,410,347 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.2% | 177,882 | 0 | 177,882 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.2% | 177,882 | 0 | 177,882 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 4% | 3,162,199 | 0 | 3,162,199 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 4.3% | 3,408,054 | 0 | 3,408,054 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 4.3% | 3,408,054 | 0 | 3,408,054 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 4.3% | 3,408,054 | 0 | 3,408,054 | /s/ Mark N. Lampert | Mark N. Lampert |